NCT01563497View on ClinicalTrials.gov

A Study Comparing PF-05089771 TS Tablet to PF-05089771 TS Oral Dispersion In The Fasted State And To PF-05089771 TS Tablet In The Fasted And Fed State

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Pain
Interventions
DRUG

PF-05089771

Oral dispersion TS formulation- fasted

DRUG

PF-05089771

Tablets TS formulation- fasted

DRUG

PF-05089771

Tablets TS formulation- fed

Trial Locations (1)

B-1070

Pfizer Investigational Site, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01563497 - A Study Comparing PF-05089771 TS Tablet to PF-05089771 TS Oral Dispersion In The Fasted State And To PF-05089771 TS Tablet In The Fasted And Fed State | Biotech Hunter | Biotech Hunter